{
    "startDate": "2020-01-01",
    "endDate": "2020-09-30",
    "year": "2020",
    "quarter": "Q3",
    "symbol": "BHVN",
    "data": {
        "bs": [
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 39811000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 217118000
            },
            {
                "label": "Contingently redeemable non-controlling interests",
                "concept": "RedeemableNoncontrollingInterestEquityCarryingAmount",
                "unit": "usd",
                "value": 60000000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 43976000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 62418000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 62418000
            },
            {
                "label": "Total shareholders\u2019 equity (deficit) attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -212379000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 20131000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 20131000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssets",
                "unit": "usd",
                "value": 23251000
            },
            {
                "label": "Marketable securities",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 229983000
            },
            {
                "label": "Non-controlling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -1439000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 708285000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 103419000
            },
            {
                "label": "Long-term debt",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 264135000
            },
            {
                "label": "Long-term debt",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 264135000
            },
            {
                "label": "Equity method investment",
                "concept": "EquityMethodInvestments",
                "unit": "usd",
                "value": 1866000
            },
            {
                "label": "Equity method investment",
                "concept": "EquityMethodInvestments",
                "unit": "usd",
                "value": 1866000
            },
            {
                "label": "Equity method investment",
                "concept": "EquityMethodInvestments",
                "unit": "usd",
                "value": 1866000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 14590000
            },
            {
                "label": "Trade receivables, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 79522000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -1521433000
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total liabilities and shareholders' equity (deficit)",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 782015000
            },
            {
                "label": "Liability related to sale of future royalties, net",
                "concept": "bhvn:LiabilityForSaleOfFutureRoyaltiesCarryingAmountNoncurrent",
                "unit": "usd",
                "value": 318594000
            },
            {
                "label": "Mandatorily redeemable preferred shares, net",
                "concept": "SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent",
                "unit": "usd",
                "value": 119456000
            },
            {
                "label": "Derivative liabilities",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1940000
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 935833000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 316231000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 316231000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 782015000
            },
            {
                "label": "Total shareholders' equity (deficit)",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -213818000
            },
            {
                "label": "Total shareholders' equity (deficit)",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -213818000
            },
            {
                "label": "Current portion of mandatorily redeemable preferred shares",
                "concept": "SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent",
                "unit": "usd",
                "value": 46875000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 126267000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 126267000
            },
            {
                "label": "Accumulated other comprehensive income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 251000
            },
            {
                "label": "Common shares, no par value; 200,000,000 shares authorized as of September 30, 2020 and December 31, 2019; 59,707,780 and 52,385,283 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 1205384000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 8802000
            }
        ],
        "cf": [
            {
                "label": "Change in fair value of derivatives",
                "concept": "bhvn:FairValueAdjustmentOfDerivativeLiability",
                "unit": "usd",
                "value": 7071000
            },
            {
                "label": "Payments for leasehold improvements",
                "concept": "PaymentsForTenantImprovements",
                "unit": "usd",
                "value": 1600000
            },
            {
                "label": "Payments for intangible assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 41500000
            },
            {
                "label": "Proceeds from issuance of mandatorily redeemable preferred shares",
                "concept": "ProceedsFromIssuanceOfMandatoryRedeemableCapitalSecurities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Payments of issuance costs",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 2300000
            },
            {
                "label": "Loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -3472000
            },
            {
                "label": "Loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -3472000
            },
            {
                "label": "Loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -3472000
            },
            {
                "label": "Loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -3472000
            },
            {
                "label": "Proceeds from issuance of common shares",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 283333000
            },
            {
                "label": "Cash paid for income taxes",
                "concept": "IncomeTaxesPaidNet",
                "unit": "usd",
                "value": 1406000
            },
            {
                "label": "Proceeds from exercise of warrants",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherNoncurrentAssets",
                "unit": "usd",
                "value": 45000
            },
            {
                "label": "Proceeds from obligation to perform R&D services",
                "concept": "bhvn:ProceedsFromServiceObligation",
                "unit": "usd",
                "value": 2124000
            },
            {
                "label": "Payment of term loan commitment fee",
                "concept": "PaymentsOfDebtIssuanceCosts",
                "unit": "usd",
                "value": 2000000
            },
            {
                "label": "Effect of exchange rate changes on cash, cash equivalents and restricted cash",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": 324000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 27898000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 1501000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 46088000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 18124000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "IncreaseDecreaseInOtherNoncurrentLiabilities",
                "unit": "usd",
                "value": 62000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 4625000
            },
            {
                "label": "Non-cash expense related to license agreement",
                "concept": "IssuanceOfStockAndWarrantsForServicesOrClaims",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Non-cash share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 43206000
            },
            {
                "label": "Non-cash share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 43206000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 769457000
            },
            {
                "label": "Proceeds from sale of contingently redeemable non-controlling interests",
                "concept": "bhvn:ProceedsFromSaleOfContingentlyRedeemableNoncontrollingInterest",
                "unit": "usd",
                "value": 60000000
            },
            {
                "label": "Proceeds from exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 17815000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -490641000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 2564000
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -274834000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -550499000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -550499000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -550499000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -550499000
            },
            {
                "label": "Net increase in cash, cash equivalents and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 4306000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 65410000
            },
            {
                "label": "Proceeds from issuance of long-term debt",
                "concept": "ProceedsFromIssuanceOfLongTermDebt",
                "unit": "usd",
                "value": 264000000
            },
            {
                "label": "Proceeds from sale of future royalties",
                "concept": "bhvn:ProceedsSaleOfFutureRoyaltiesNetOfIssuanceCosts",
                "unit": "usd",
                "value": 147476000
            },
            {
                "label": "Non-cash interest expense on mandatorily redeemable preferred shares",
                "concept": "InterestExpenseDebtExcludingAmortization",
                "unit": "usd",
                "value": 19864000
            },
            {
                "label": "Non-cash interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 31950000
            },
            {
                "label": "Non-cash interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 31950000
            },
            {
                "label": "Non-cash interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 31950000
            },
            {
                "label": "Other non-cash items",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -80000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 230233000
            },
            {
                "label": "Repayment of principal for finance leases",
                "concept": "FinanceLeasePrincipalPayments",
                "unit": "usd",
                "value": 991000
            },
            {
                "label": "Repayment of principal for finance leases",
                "concept": "FinanceLeasePrincipalPayments",
                "unit": "usd",
                "value": 991000
            },
            {
                "label": "Trade receivables, net",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 79522000
            }
        ],
        "ic": [
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 339936000
            },
            {
                "label": "Less: Net loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1439000
            },
            {
                "label": "Less: Net loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1439000
            },
            {
                "label": "Less: Net loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1439000
            },
            {
                "label": "Weighted average common shares outstanding - basic and diluted (shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 58282697
            },
            {
                "label": "Weighted average common shares outstanding - basic and diluted (shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 58282697
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -550499000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -550499000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -550499000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -550499000
            },
            {
                "label": "Non-cash interest expense on mandatorily redeemable preferred shares",
                "concept": "InterestExpenseDebt",
                "unit": "usd",
                "value": 19864000
            },
            {
                "label": "Non-cash interest expense on mandatorily redeemable preferred shares",
                "concept": "InterestExpenseDebt",
                "unit": "usd",
                "value": 19864000
            },
            {
                "label": "Net loss per share attributable to Biohaven Pharmaceutical Holding Company Ltd - basic and diluted (in dollars per share)",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -9.42
            },
            {
                "label": "Net loss per share attributable to Biohaven Pharmaceutical Holding Company Ltd - basic and diluted (in dollars per share)",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -9.42
            },
            {
                "label": "Gross profit",
                "concept": "GrossProfit",
                "unit": "usd",
                "value": 20787000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -474688000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 155539000
            },
            {
                "label": "Change in fair value of derivatives",
                "concept": "bhvn:FairValueAdjustmentOfDerivatives",
                "unit": "usd",
                "value": 7071000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 5341000
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 495475000
            },
            {
                "label": "Non-cash interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 31950000
            },
            {
                "label": "Non-cash interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 31950000
            },
            {
                "label": "Non-cash interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 31950000
            },
            {
                "label": "Product revenue, net",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 28513000
            },
            {
                "label": "Total other expense, net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -70470000
            },
            {
                "label": "Net loss attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -549060000
            },
            {
                "label": "Net loss attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -549060000
            },
            {
                "label": "Other",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -3278000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -545158000
            },
            {
                "label": "Loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -3472000
            },
            {
                "label": "Loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -3472000
            },
            {
                "label": "Loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -3472000
            },
            {
                "label": "Loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -3472000
            },
            {
                "label": "Cost of goods sold",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 7726000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpenseOther",
                "unit": "usd",
                "value": 4835000
            },
            {
                "label": "Foreign currency translation adjustments",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": 324000
            },
            {
                "label": "Net unrealized losses related to available-for-sale debt securities",
                "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": -73000
            },
            {
                "label": "Other comprehensive income",
                "concept": "OtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 251000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -550248000
            },
            {
                "label": "Comprehensive loss attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -548809000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -550499000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -550499000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -550499000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -550499000
            },
            {
                "label": "Less: comprehensive loss attributable to non-controlling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1439000
            }
        ]
    }
}